Clinical Trial of CT1812 in Mild to Moderate Alzheimer's Disease

Clinical trial NCT02907567 · COMPLETED

Trial details

NCT number: NCT02907567
Sponsor: Cognition Therapeutics
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Alzheimer's Disease

Start date: 2016-09-01
Primary completion: 2017-08-24
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.